Common Blood Pressure Drug Could Make Cancer Therapy Far More Powerful

The fight against cancer is one of the most important priorities in medicine today. Despite advances in treatment, cancer remains one of the leading causes of death worldwide. However, a recent study has found that a common blood pressure drug could have a significant impact on cancer therapy. The drug, called valsartan, is an angiotensin-converting enzyme (ACE) inhibitor that is commonly used to treat high blood pressure. Researchers have found that valsartan can enhance the effectiveness of cancer therapy by inhibiting angiogenesis, which is the process by which tumors create new blood vessels to feed and grow. This means that valsartan could be used in combination with other cancer treatments to improve their efficacy. The study also found that valsartan may have a synergistic effect with other cancer drugs, which could lead to increased survival and improved quality of life for cancer patients. In summary, this study has found that a common blood pressure drug could have a significant impact on cancer therapy, and opens up new avenues for the treatment of this disease.